| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | NU58DP007088 | National Initiative to Advance Health Equity in K-12 Education by Preventing Chronic Disease and Promoting Healthy Behaviors: Priority 2-Emotional Well-Being | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | NU58DP007088 | National Initiative to Advance Health Equity in K-12 Education by Preventing Chronic Disease and Promoting Healthy Behaviors: Priority 2-Emotional Well-Being | 02 | 4 | CDC | 11/10/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $199,260,628 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI190438 | Development of Oral Immunotherapy against Clostridioides difficile Transmission | 000 | 1 | NIH | 3/14/2025 | $511,553 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL167012 | A mechanistic understanding of treatment-related outcomes of sleep disordered breathing using functional near infrared spectroscopy | 000 | 3 | NIH | 2/25/2025 | $533,892 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08NS140393 | The Role of STRADA in Inhibitory Neuron Migration and Corticogenesis | 001 | 1 | NIH | 9/16/2025 | $19,498 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08NS140393 | The Role of STRADA in Inhibitory Neuron Migration and Corticogenesis | 000 | 1 | NIH | 7/29/2025 | $209,057 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI187023 | Epitope-Paratope Characteristics and IgG1 Allostery in Fc-mediated Effector Function | 000 | 1 | NIH | 8/7/2025 | $463,676 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 001 | 2 | NIH | 5/29/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01AI189332 | Molecular determinants of vaccine-induced antibody durability | 000 | 1 | NIH | 9/19/2025 | $777,495 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | S10OD038247 | PET insert Si 198 | 000 | 1 | NIH | 9/25/2025 | $1,022,134 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS120929 | Image-guided, intra-arterial delivery of antibodies to the central nervous system | 000 | 5 | NIH | 3/4/2025 | $347,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03AG095718 | Association of Peripheral Nerve Blocks with Postoperative Outcomes and Readmissions in Older Adults Undergoing Hip Fracture Surgery | 000 | 1 | NIH | 8/7/2025 | $388,750 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K24DA061154 | Effects of prenatal and postnatal cannabis use on Lactation And Maternal Bonding (LAMB) | 000 | 1 | NIH | 7/11/2025 | $171,822 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 009 | 3 | NIH | 9/18/2025 | $104,981 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 008 | 3 | NIH | 9/18/2025 | $167,709 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 005 | 3 | NIH | 9/12/2025 | $110,636 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL181475 | Cell type-specific roles of integrin CD11b in atherosclerosis regression | 000 | 1 | NIH | 8/18/2025 | $752,709 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32GM159581 | Training Program in Cellular and Molecular Membrane Biology | 000 | 1 | NIH | 8/18/2025 | $416,240 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH107615 | Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment | 000 | 10 | NIH | 3/4/2025 | $566,653 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH107615 | Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment | 001 | 10 | NIH | 7/11/2025 | $60,205 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MD019029 | Assessing intersectional, multilevel and multidimensional structural racism for English- and Spanish-speaking populations in the US | 006 | 3 | NIH | 7/17/2025 | $122,602 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MD019029 | Assessing intersectional, multilevel and multidimensional structural racism for English- and Spanish-speaking populations in the US | 005 | 3 | NIH | 7/8/2025 | $760,564 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37MH080046 | Internal Dynamics of the Postsynaptic Density | 000 | 18 | NIH | 11/18/2024 | $789,536 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS145443 | Mechanisms and intervention of cGAS signaling in brain trauma-induced neuroinflammation and neurodegeneration | 000 | 1 | NIH | 7/29/2025 | $654,218 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011804 | Strengthening Capacity in Health Research Ethics and Methodology in The Gambia | 000 | 4 | NIH | 3/12/2025 | $237,788 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL167012 | A mechanistic understanding of treatment-related outcomes of sleep disordered breathing using functional near infrared spectroscopy | 001 | 3 | NIH | 7/24/2025 | $59,322 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS117102 | Stem Cell Surface Modification to Promote Nerve Regeneration | 000 | 4 | NIH | 3/11/2025 | $272,722 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30CA284526 | ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma | 000 | 2 | NIH | 3/19/2025 | $36,338 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS120929 | Image-guided, intra-arterial delivery of antibodies to the central nervous system | 001 | 5 | NIH | 8/5/2025 | $38,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 007 | 3 | NIH | 9/17/2025 | $49,384 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 004 | 3 | NIH | 9/12/2025 | $110,636 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 003 | 3 | NIH | 9/10/2025 | $66,666 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG1HD113162 | Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | 003 | 3 | NIH | 9/10/2025 | $150,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 001 | 2 | NIH | 8/5/2025 | $564 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 000 | 2 | NIH | 3/6/2025 | $39,221 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS147428 | Role of Task-Specific Context in Sequential Motor Skill learning | 000 | 1 | NIH | 9/24/2025 | $42,433 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21NS142439 | Developing a toolbox to study proteome plasticity in brain endothelial cells | 000 | 1 | NIH | 7/17/2025 | $427,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG077541 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia | 000 | 4 | NIH | 3/10/2025 | $552,372 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG077541 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia | 001 | 4 | NIH | 6/17/2025 | $49,099 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33HL168723 | Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma. | 000 | 3 | NIH | 8/26/2025 | $361,930 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | RF1MH134721 | A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men | 000 | 3 | NIH | 8/26/2025 | $2,187,174 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032225 | The Role of Testosterone on Mediating Sex and Gender Influences on Chronic Orofacial Pain Conditions | 002 | 3 | NIH | 8/6/2025 | $215,441 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162120 | Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis | 001 | 4 | NIH | 7/24/2025 | $63,154 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162120 | Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis | 000 | 4 | NIH | 2/19/2025 | $568,382 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW013007 | Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program | 000 | 1 | NIH | 7/23/2025 | $248,306 |
|
